Ads
related to: cprx newslp.stockstotrade.com has been visited by 10K+ users in the past month
Search results
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
Zacks via Yahoo Finance· 11 months agoCatalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North...
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals added a second product to its lineup Wednesday with a $160 million deal for...
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past...
Simply Wall St. via Yahoo Finance· 2 months agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if...
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans to knock off Catalyst Pharmaceuticals' only approved drug....
Catalyst Pharma, The No. 1 Tech Leader, Just Trounced Third-Quarter Expectations
Investor's Business Daily· 2 years agoCatalyst Pharmaceuticals trounced Wall Street's third-quarter forecasts and raised its full-year...
We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, bluebird BLUE...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...
Zacks.com featured highlights include Tsakos Energy, AVEO Pharmaceuticals and Catalyst...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – September 12, 2022 – Stocks in this week’s article are Tsakos...
Biotech Leader Plunges On New Offering Of 10 Million Shares
Investor's Business Daily· 5 months agoIBD Sector Leader Catalyst Pharmaceuticals plunged more than 10% on Friday after news that the...
